Investor's Business Daily on MSN2h
Is Moderna Stock A Sell As RFK Jr. Reportedly Mulls A Massive Funding Pull?
Moderna stock skidded on reports Robert F. Kennedy Jr. is considering pulling funding for its bird flu vaccine. Is MRNA stock ...
Moderna: Patent Litigation Win Masks Underperformance, Unlikely To Pay Out
Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...
Fierce Pharma6h
Pfizer, BioNTech notch US win—and loss in Germany—amid high-stakes patent fight with Moderna
As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...
German court rules Pfizer, BioNTech violated Moderna's COVID-19 vaccine patent
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .
Moderna (MRNA) Stock Climbs as CEO and Director Make Strategic Insider Purchases
Shares of the American pharmaceutical company Moderna (MRNA) climbed over 8% in pre-market trading following strategic ...
Moderna Eyes 2027 Launch for Cancer Vaccine Developed With Merck
Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...
Why Moderna (MRNA) Stock Is Rallying Today
A German court ruled that BioNTech (BNTX) and Pfizer (PFE) have to pay Moderna damages because they infringed on Moderna ...
Moderna aims 2027 approval for Merck-partnered cancer shot
Moderna (MRNA) stock in focus as the company aims a 2027 marketing nod for Merck (MRK) partnered skin cancer vaccine. Read ...
Can Moderna's Aggressive Cost Cuts Help Turn Things Around for Its Stock?
For now, Moderna may be a good stock to put on a watch list, but it's likely too risky and volatile for the vast majority of ...
Fierce Pharma2d
Arbutus, Genevant expand COVID patent feud with Moderna with 5 international lawsuits
Arbutus Biopharma and Genevant Sciences are broadening the scope of their patent infringement claims against Moderna with ...
Zacks Investment Research on MSN5h
Here's Why Moderna Stock Soared 16% on Wednesday
Shares of Moderna MRNA rose nearly 16% yesterday after a couple of SEC filings showed that two board members bought shares on ...